Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 4
1973 2
1975 1
1976 2
1978 1
1979 1
1980 3
1981 2
1984 2
1985 6
1986 4
1987 4
1988 5
1989 5
1990 9
1991 9
1992 1
1993 9
1994 8
1995 12
1996 7
1997 9
1998 11
1999 10
2000 20
2001 9
2002 13
2003 16
2004 10
2005 12
2006 12
2007 11
2008 14
2009 27
2010 12
2011 17
2012 12
2013 20
2014 14
2015 22
2016 15
2017 27
2018 17
2019 18
2020 22
2021 15
2022 19
2023 32
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

497 results

Results by year

Filters applied: . Clear all
Page 1
Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.
Meyers DE, Basha HI, Koenig MK. Meyers DE, et al. Tex Heart Inst J. 2013;40(4):385-94. Tex Heart Inst J. 2013. PMID: 24082366 Free PMC article. Review.
The typical cardiac manifestations of mitochondrial disease--hypertrophic and dilated cardiomyopathy, arrhythmias, left ventricular myocardial noncompaction, and heart failure--can worsen acutely during a metabolic crisis. ...We focus on current practice in the diag …
The typical cardiac manifestations of mitochondrial disease--hypertrophic and dilated cardiomyopathy, arrhythmias, left ventri …
Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: Sudden cardiac death in the young.
D'Ascenzi F, Valentini F, Pistoresi S, Frascaro F, Piu P, Cavigli L, Valente S, Focardi M, Cameli M, Bonifazi M, Metra M, Mondillo S. D'Ascenzi F, et al. Trends Cardiovasc Med. 2022 Jul;32(5):299-308. doi: 10.1016/j.tcm.2021.06.001. Epub 2021 Jun 22. Trends Cardiovasc Med. 2022. PMID: 34166791 Review.
Comparing the causes of SCD between athletes and non-athletes, non-ischemic left ventricular scar (NILVS) (5.1% vs. 1.1%, p=0.01) was more frequent in the former, while coronary artery disease (CAD) (19.6% vs. 9.1%, p=0.009), arrhythmogenic cardiomyopathy (ACM) (11.5% vs. …
Comparing the causes of SCD between athletes and non-athletes, non-ischemic left ventricular scar (NILVS) (5.1% vs. 1.1%, p=0.01) was more f …
Hypertrophic Obstructive Cardiomyopathy.
Batzner A, Schäfers HJ, Borisov KV, Seggewiß H. Batzner A, et al. Dtsch Arztebl Int. 2019 Jan 25;116(4):47-53. doi: 10.3238/arztebl.2019.0047. Dtsch Arztebl Int. 2019. PMID: 30855006 Free PMC article. Review.
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by mutations in a number of genes. ...
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by mutations in a number of genes. ...
Hypertrophic cardiomyopathy.
Subasic K. Subasic K. Nurs Clin North Am. 2013 Dec;48(4):571-84. doi: 10.1016/j.cnur.2013.09.001. Nurs Clin North Am. 2013. PMID: 24295188 Free article. Review.
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant, cardiovascular disorder that carries the risk of sudden cardiac death. ...
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant, cardiovascular disorder that carries the risk of sudden cardiac de …
Postablation Atrial Arrhythmias.
Kapa S. Kapa S. Card Electrophysiol Clin. 2019 Dec;11(4):573-582. doi: 10.1016/j.ccep.2019.08.008. Card Electrophysiol Clin. 2019. PMID: 31706466 Review.
In addition, postablation atrial arrhythmias may be more common in certain types of cardiomyopathy, including hypertrophic cardiomyopathy....
In addition, postablation atrial arrhythmias may be more common in certain types of cardiomyopathy, including hypertrophic …
Cardiomyopathies in children: An overview.
Tsatsopoulou A, Protonotarios I, Xylouri Z, Papagiannis I, Anastasakis A, Germanakis I, Patrianakos A, Nyktari E, Gavras C, Papadopoulos G, Meditskou S, Lazarou E, Miliou A, Lazaros G. Tsatsopoulou A, et al. Hellenic J Cardiol. 2023 Jul-Aug;72:43-56. doi: 10.1016/j.hjc.2023.02.007. Epub 2023 Mar 3. Hellenic J Cardiol. 2023. PMID: 36870438 Free article. Review.
The annual incidence of 1 per 100,000 children appears higher during the first two years of life. Dilated and hypertrophic cardiomyopathy phenotypes share an incidence of 60% and 25%, respectively. Arrhythmogenic right ventricular cardiomyopathy (ARVC), restr …
The annual incidence of 1 per 100,000 children appears higher during the first two years of life. Dilated and hypertrophic cardiom …
Metalloproteinases and Hypertrophic Cardiomyopathy: A Systematic Review.
Serraino GF, Jiritano F, Costa D, Ielapi N, Napolitano D, Mastroroberto P, Bracale UM, Andreucci M, Serra R. Serraino GF, et al. Biomolecules. 2023 Apr 11;13(4):665. doi: 10.3390/biom13040665. Biomolecules. 2023. PMID: 37189412 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is a genetic condition determined by an altered collagen turnover of the extracellular matrix. ...
Hypertrophic cardiomyopathy (HCM) is a genetic condition determined by an altered collagen turnover of the extracellular matri …
The heart in RASopathies.
Delogu AB, Limongelli G, Versacci P, Adorisio R, Kaski JP, Blandino R, Maiolo S, Monda E, Putotto C, De Rosa G, Chatfield KC, Gelb BD, Calcagni G. Delogu AB, et al. Am J Med Genet C Semin Med Genet. 2022 Dec;190(4):440-451. doi: 10.1002/ajmg.c.32014. Epub 2022 Nov 21. Am J Med Genet C Semin Med Genet. 2022. PMID: 36408797 Review.
The cardiovascular phenotype associated with RASopathies has expanded far beyond the original descriptions of pulmonary valve stenosis by Dr Jaqueline Noonan in 1968 and hypertrophic cardiomyopathy by Hirsch et al. in 1975. Because of the common underlying RAS/MAPK …
The cardiovascular phenotype associated with RASopathies has expanded far beyond the original descriptions of pulmonary valve stenosis by Dr …
Current therapies for hypertrophic cardiomyopathy: a systematic review and meta-analysis of the literature.
Bayonas-Ruiz A, Muñoz-Franco FM, Sabater-Molina M, Oliva-Sandoval MJ, Gimeno JR, Bonacasa B. Bayonas-Ruiz A, et al. ESC Heart Fail. 2023 Feb;10(1):8-23. doi: 10.1002/ehf2.14142. Epub 2022 Oct 1. ESC Heart Fail. 2023. PMID: 36181355 Free PMC article. Review.
AIMS: The aim of this study was to synthesize the evidence on the effect of the current therapies over the pathophysiological and clinical characteristics of patients with hypertrophic cardiomyopathy (HCM). METHODS AND RESULTS: A systematic review and meta-analysis …
AIMS: The aim of this study was to synthesize the evidence on the effect of the current therapies over the pathophysiological and clinical c …
Hypertrophic Cardiomyopathy: Current Treatment and Future Options.
Sebastian SA, Panthangi V, Singh K, Rayaroth S, Gupta A, Shantharam D, Rasool BQ, Padda I, Co EL, Johal G. Sebastian SA, et al. Curr Probl Cardiol. 2023 Apr;48(4):101552. doi: 10.1016/j.cpcardiol.2022.101552. Epub 2022 Dec 16. Curr Probl Cardiol. 2023. PMID: 36529236 Review.
Hypertrophic cardiomyopathy (HCM) is a disease involving the cardiac sarcomere. ...
Hypertrophic cardiomyopathy (HCM) is a disease involving the cardiac sarcomere. ...
497 results